Category Archives: Advocacy

The Moon, Measles and Misinformation

Saturday marks the 50th anniversary of the lunar landing.  On July 20, 1969, Neil Armstrong and Buzz Aldrin became the first humans to walk on the moon.  This is fact.  Somehow, though, conspiracy theories about the moon landing being a … Continue reading

Posted in Advocacy | Leave a comment

Preventing Firearm Related Violence

I’ve written on the topic of firearm violence before; in December 2015 when ACP was advocating for lifting the ban on federally funded research into this public health issue and again in May 2016 with the online publication of the … Continue reading

Posted in Advocacy, Healthcare Policy | Leave a comment

Let’s hold our elected officials accountable

I have been criticized before for being too political in these posts.  But I maintain that as internists, we have to recognize that the decisions of legislators and policymakers have a profound impact on our country’s health. And, if we’re … Continue reading

Posted in Advocacy, Healthcare Policy | Leave a comment

Stemming the Escalating Cost of Prescription Drugs

Back in October, I wrote about escalating drug prices.  Last week, ACP President Nitin Damle was testifying before Congress about the CREATES Act (“Creating and Restoring Equal Access to Equivalent Samples Act of 2016”).  This bill, if it were to … Continue reading

Posted in Advocacy, Healthcare Policy | Leave a comment

Annals This Week: Physicians, Patients and Firearms

Last December, I wrote about ACP activity to counteract firearm violence.  This week, the Annals of Internal Medicine published a review on physician practice regarding asking about firearms. It is striking that 40% of Americans are worried they could be … Continue reading

Posted in Advocacy | Leave a comment

Gun Violence: Still A Public Health Issue

The three-year anniversary of the Sandy Hook Elementary School shooting in Newtown is cause for reflection here in Connecticut.   Sadly, little has changed since then.  However, for the first time in 19 years we’ve seen a glimmer of hope to … Continue reading

Posted in Advocacy, Healthcare Policy | Leave a comment

Escalating Drug Prices Are Unsustainable

The release of several new, astonishingly expensive, specialty medications has renewed the discussion over prescription drug pricing.  The new hepatitis C drugs, Harvoni ($94,500 for a 12-week course) and Sovaldi ($84,000 for a 12-week course) are emblematic.  Kaiser Health News … Continue reading

Posted in Advocacy, Healthcare Policy, High Value Care | Leave a comment